News

Isomerase discovers and develops molecules that target peptidyl-prolyl isomerases including cyclophilins. The acquisition intends to further improve the collaboration between the firms and speed up NeuroVive’s research and

Selinexor is the company’s oral selective inhibitor of Nuclear Export (SINE) compound. It binds to and inhibits the nuclear export protein XPO1, resulting in the accumulation of tumor

Imetelstat, discovered by Geron, is a potent and specific inhibitor of telomerase that is administered by intravenous infusion. The clinical trial, also referred to as the IMerge study,

TheraKine has developed sustained release delivery technology platforms for injectable local delivery of biologic agents and live cells. Cell Care uses stem cells to treat degenerative and inflammatory

Ketamine, which has been extensively used as an intravenous anesthetic for many years, has been also reported to be effective as a rapid treatment for a variety of

New investor Deerfield Management Company led the financing, which also included participation from new investor Casdin Capital as well as existing investors Fidelity Management and Research Company, WuXi

These tests will be used to help identify patients for MedImmune’s MEDI4893 and MEDI3902 clinical programs, which are being conducted within the COMBACTE consortium to explore the use

ThromboGenics hopes to be able to reduce the risk of disease progression to proliferative diabetic retinopathy (PDR) by inducing a total PVD using ocriplasmin. PDR is the major

The EORTC intergroup trial 1206:"A randomised phase II study to evaluate the efficacy and safety of chemotherapy vs androgen deprivation therapy (ADT) in patients with recurrent and/or metastatic,